Acne Drugs Market By Drug Class ( Antibiotics, Antimicrobial, Anti-Inflammatory Drug, Combination Medications, Oral Retinoid, Hormonal Agents, Topical Retinoid ), By Type of Drug ( Prescribed, OTC drugs ), By Mode of Administration ( Topical, Oral ), Industry Trends, Estimation & Forecast, 2017 - 2025

Acne Drugs Market is expected to generate $7,343 by the end of 2025.

Market Overview:

The global acne market is experiencing a promising growth in recent times as disposable income of consumers especially of the middle-class is increased and their tendency to spend more on personal care products. Acne is described as a chronic inflammatory skin condition that arises in several different forms such as blackheads, whiteheads, pimples, cysts or nodules. It is common amongst adolescents and young adults especially in women. As women account for around 75% of the adult cases, they play crucial role in the growth of the market. Though the global acne market is very small in market size; it holds immense growth potential owing to rise in consumers fast food consumption and expenditure on health. Increasing prevalence of acne, increase in consumer awareness about available and upcoming acne treatments, increasing adoption of sedentary lifestyle, and increased expenditure on drugs from various emerging economies are likely to drive the global acne drugs market in near future. However, the market faces various challenges such as prices of drugs, intense competition, government regulations, adverse effects of drugs, and dearth of skilled dermatologists that may hamper the market growth. The acne market has ample research and development opportunities to develop new treatments for acne. Moreover, presence of large number of biotech and pharma companies in Asian countries offer growth opportunities for the market. The report provides detailed qualitative and quantitative analysis of the global acne drugs market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely drug class, drug type, and mode of administration in each of the major regions of the world.

Acne Drugs Market Segmentation

By Drug Class • Antibiotics • Antimicrobial • Anti-Inflammatory Drug • Combination Medications • Oral Retinoid • Hormonal Agents • Topical Retinoid. By Type of Drug • Prescribed • OTC drugs By Mode of Administration • Topical • Oral By Geography • North America o U.S. o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o Japan o China o India o Rest of Asia-Pacific • Rest of the World o Middle East o Latin America o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. ACNE DRUGS MARKET OVERVIEW 2.1. ACNE DRUGS MARKET INTRODUCTION 2.2. GLOBAL ACNE DRUGS MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Acne Drugs Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL ACNE DRUGS MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Acne Drugs Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL ACNE DRUGS MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Acne Drugs Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL ACNE DRUGS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Acne Drugs Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL ACNE DRUGS MARKET PRICE TREND, 2017-2025 2.6.1. Global Acne Drugs Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL ACNE DRUGS MARKET BY DRUG CLASS, 2017-2025 3.1. ANTIBIOTICS 3.2. ANTIMICROBIAL 3.3. ANTI-INFLAMMATORY DRUG 3.4. GLOBAL ACNE DRUGS MARKET REVENUE BY DRUG CLASS, 2017-2025 3.4.1. Global Acne Drugs Market Revenue (Million USD) and Share (%) By Drug Class, 2017-2025 3.4.2. Antibiotics Market Revenue and Growth Rate, 2017-2025 3.4.3. Antimicrobial Market Revenue and Growth Rate, 2017-2025 3.4.4. Anti-Inflammatory Drug Market Revenue and Growth Rate, 2017-2025 3.5. GLOBAL ACNE DRUGS MARKET PRODUCTION BY DRUG CLASS, 2017-2025 3.5.1. Global Acne Drugs Market Production (Volume) and Share (%) By Drug Class, 2017-2025 3.5.2. Antibiotics Market Production and Growth Rate, 2017-2025 3.5.3. Antimicrobial Market Production and Growth Rate, 2017-2025 3.5.4. Anti-Inflammatory Drug Market Production and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other drug class segment. CHAPTER 4. GLOBAL ACNE DRUGS MARKET BY MODE OF ADMINISTRATION, 2017-2025 4.1. TOPICAL 4.2. ORAL 4.3. GLOBAL ACNE DRUGS MARKET REVENUE BY MODE OF ADMINISTRATION, 2017-2025 4.3.1. Global Acne Drugs Market Revenue (Million USD) and Share (%) By Mode of Administration, 2017-2025 4.3.2. Topical Market Revenue and Growth Rate, 2017-2025 4.3.3. Oral Market Revenue and Growth Rate, 2017-2025 4.4. GLOBAL ACNE DRUGS MARKET CONSUMPTION BY MODE OF ADMINISTRATION, 2017-2025 4.4.1. Global Acne Drugs Market Consumption (Volume) and share (%) By Mode of Administration, 2017-2025 4.4.2. Topical Market Consumption and Growth Rate, 2017-2025 4.4.3. Oral Market Consumption and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for type of drug segment. CHAPTER 5. GLOBAL ACNE DRUGS MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL ACNE DRUGS MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Acne Drugs Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL ACNE DRUGS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL ACNE DRUGS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Acne Drugs Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Acne Drugs Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL ACNE DRUGS MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL ACNE DRUGS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Acne Drugs Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL ACNE DRUGS REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Acne Drugs Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. ACNE DRUGS MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Acne Drugs Market Share (%) of Top 3 Manufacturers 8.3.2. Acne Drugs Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL ACNE DRUGS MANUFACTURERS ANALYSIS 9.1. VALEANT PHARMACEUTICAL INTERNATIONAL, INC. 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Acne Drugs Product Details 9.1.4. Valeant Pharmaceutical International, Inc. Acne Drugs Production, Revenue and Gross Margin 9.2. GALDERMA S.A. 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Acne Drugs Product Details 9.2.4. Galderma S.A. Acne Drugs Production, Revenue and Gross Margin 9.3. ALMA LASERS LTD. 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Acne Drugs Product Details 9.3.4. Alma Lasers Ltd. Acne Drugs Production, Revenue and Gross Margin 9.4. ALLERGAN PLC. 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Acne Drugs Product Details 9.4.4. Allergan plc. Acne Drugs Production, Revenue and Gross Margin 9.5. SYNERON MEDICAL LTD. 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Acne Drugs Product Details 9.5.4. Syneron Medical Ltd. Acne Drugs Production, Revenue and Gross Margin 9.6. LUMENIS LTD. 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Acne Drugs Product Details 9.6.4. Lumenis Ltd. Acne Drugs Production, Revenue and Gross Margin 9.7. STIEFEL LABORATORIES INC. 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Acne Drugs Product Details 9.7.4. Stiefel Laboratories Inc. Acne Drugs Production, Revenue and Gross Margin 9.8. VERILUX, INC. 9.8.1. Business Overview 9.8.2. Company Basic Information 9.8.3. Acne Drugs Product Details 9.8.4. Verilux, Inc. Acne Drugs Production, Revenue and Gross Margin 9.9. JOHNSON AND JOHNSON 9.9.1. Business Overview 9.9.2. Company Basic Information 9.9.3. Acne Drugs Product Details 9.9.4. Johnson and Johnson Acne Drugs Production, Revenue and Gross Margin CHAPTER 10. ACNE DRUGS MARKET VALUE CHAIN ANALYSIS 10.1. ACNE DRUGS INDUSTRIAL CHAIN ANALYSIS 10.2. ACNE DRUGS KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials

• Valeant Pharmaceutical International, Inc.
• Galderma S.A.
• Alma Lasers Ltd.
• Allergan plc.
• Syneron Medical Ltd.
• Lumenis Ltd.
• Stiefel Laboratories Inc.
• Verilux, Inc.
• Johnson and Johnson

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS